Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can you adopt me and buy me $10k worth of shares? Lol jk
Congrats on the incoming cash infusion! Interested to see what a full Q with Prasco/Burel looks like.
$ELTP$
Needs to remove one or the other - 2 line items dedicated to antimetabolite ANDAs when we’ve only discussed and filed 1. Update the one to likely Methotrexate with last known $42M market number and delete the other.
Are they being manufactured at the new/second site or just packaged and stored there?
Why is it up from a little over 2 and a half pennies?
I’d take it off the list. We know how many ANDAs under review and each of their reported market sizes. The antimetabolite was $42M market size at announcement of filing.
+TAGI/Precision Dose
Happy Easter folks!
$ELTP$
Think 26 should be removed in favor of 27?
What ya plotting?
I hope I’m right too, also simply posing the question. Nothing is a sure thing but it just seems like it would make more sense to be concerned if the company had a track record of failing to get generics approved. Thus far, that has not been the case.
I am optimistic that the growing revenues, the facility expansion, the multiple ANDAs under review, and the further ANDAs in trials and formulation will lead to a higher PPS.
Which generic has Elite failed to get approval for in the past?
Correct. That would be less than the annual revenue if we’re around roughly $60M currently and projected to grow, if evidenced by nothing else than expanding the facility. 😂
They just on a St Paddy’s Day hiatus??
That’s interesting. Is it common for the brand to discontinue the original drug once several generic alternatives are available?
Do you know if additional generics can still get approved after the brand is discontinued? Can they still rely on the brand’s initial trial data for bioequivalency even if the company has discontinued the branded/original drug?
That, Doug Plassche and crew actually getting the API from raw to finished product and Kirko lining up customers (though I’m sure Adderall is largely selling itself currently). And our 3PL partner getting said product to pharmacies and such.
Several potential points of failure but Elite has managed the process pretty well so far.
Irish car bombs… been a minute since I’ve had one of those but they’re legit 👌
Long live the King 👑 🗡️
$ELTP$
Don’t jinx it lol
“What has changed this time ??”
Precisely. So why was the drop warranted?
*taps temple*
Quiet as a church mouse
So which is it? Ignored or not?
Don’t think I did. Got drunk early today, huh?
Work it, boiler rat
This is your brain
This is your brain on drugs
Guess I’ll move more money over then, appreciate the heads up!! Lol!
Nasrat is a dude. Are you perpetually high and/or drunk?
Oof, sorry to hear that.
Okay so you’d officially prefer bankruptcy then?
They’ve started paying in cash.
Would you have preferred bankruptcy over dilution? Or crippling debt payments like what happened to Lannett?
No one cares
Sounds like a case of bullied in grade school :(
Try not to dwell on it
Elite also never traded at 2 cents flat, closer to 2.62 or so but more typical half truths from the dipshit (you)
Good try dipshit!
Max is probably 200-230M shares.
Is that more or less than 430M authorized?
Dumb paid shill clown.
Hundreds of millions? Lol barely. Typical fear mongering but that’s your role.
All depends on the closing prices of most of those shares. They clearly have the authorized available to accommodate, almost 430M in wiggle room.
Now squirm some more, bottom feeder.
Sure, chief
Ya you been wrong plenty
I too always post on boards I have no vested interest in, or no plan to invest in.
Not
Nearly 9 years since a post here lmao, boiler room calling in everyone they can think of!